Programmbereich Infektionen
Zelluläre Mikrobiologie
Mission
Projekte
Drittmittel
Methoden
Publikationen
Mitarbeiter/innen
Drittmittel
- Leibniz Research Alliance INFECTIONS'21 - Transmission Control of Infections in the 21st Century (Speaker), -2020
- Leibniz-Wettbewerb Chronic quiescence - maintenance of hematopoiesis and immunological memory in health and latent infection, and its disruption in chronic inflammation (CHROQ), 2019-2022
- SAW Projekt 566 The lung microbiota at the interface between airway epithelium and environment, -2019
- German Center for Infection Research (DZIF) – Thematical Translational Unit Tuberculosis (TTU-TB) Neutrophil signatures in tuberculosis, -2020
- BMBF Africa: TB Sequel Comorbidities, risk factors and long-term sequelae defining the individual outcome and public health impact of TB disease, -2020
- EVOLung Iron metabolism genes in the interaction between microbiota, host and tuberculosis, -2020
- ANTI-TB Targeted nanocarrier for anti-tuberculosis drug delivery (Speaker), -2020
- DFG Russia-Germany Correlates of exacerbated and ameliorated pathogenesis in experimental and clinical tuberculosis, -2020
- DFG International Graduate School 1911 Immunoregulation of Inflammation in Allergy and Infection Project B7 Cross-talk between mycobacteria and neutrophils and its impact on tuberculosis persistence, -2022
- BMG MetaCorDia: Metagenomik Labor für den Nachweis von Coronaviren in respiratorischen Patientenmaterialien & Strukturierte medizinische Ersteinschätzung (SmE), schnelle Diagnostik im Rahmen eines Corona Virus Ausbruchs und neue antivirale Stoffe am FZB, 1.1.-31.12.2020
- FLAV4AMR Horizon 2020 Flavodoxin inhibitors to kill resistant bacteria, -2019
- VITALITY Horizon 2020 (EDCTP) Vitamin D for AdoLescents with HIV to reduce musculoskeletal morbidity and ImmunopaThologY (VITALITY)2020-2025
- ETBRA Horizon 2020 (IMI) : European tuberculosis regimen accelerator, - 2020-2025
Kooperationspartner
- Alexander Apt, Vladimir Yeremeev, Central Institute for Tuberculosis, Moscow 107564, Russia; Properties on susceptibility and resistance in tuberculosis
- Claus Feldmann, KIT, Karlsruhe; Lea Ann Dailey, University Halle; Katharina Schwarz, ITEM, Hannover; Robert Gieseler, Rodos Targospheres, Hannover; Klaus-Michael Lehr, HIPS, Saarbrücken; Corvin Nycolat, Scripps, La Jolla, USA: Targeted nanocarrier for anti-TB drug delivery
- Esther Meyron-Holtz, Technion-Israel Institute of Technology, Haifa, Israel: Iron in tuberculosis
- John Baines, MPI for Evolutionar Biology, Plön; Ken Bruce, Kings College, London, UK: Pulmonary microbiota in infection and immunity
- Albert Haas, University of Bonn: Trafficking of intracellular bacteria
- Albert Sickmann, ISAS, Dortmund; Frank Schmidt, Weill Cornell Medicine Qatar; Moran Benhar, Technion-Israel Institute of Technology, Haifa, Israel: Proteomics of host - pathogen interactions
- Wolfgang Streit, University Hamburg; Joerg Steinmann, University Essen; Jan Rupp, UzL, Lübeck: Stenotrophomonas maltophilia
- Gareth Griffiths, Oslo; Rudi Reimer, HPI, Hamburg; Alke Meents, DESY, Hamburg: High resolution imaging of infection
- Kerstin Schepanski, TROPOS, Leipzig; Gülsah Gabriel, HPI, Hamburg; Anne Paschke, Wolfgang Hein, GIGA, Hamburg: Aerosol transmission of airborne pathogens
- Thomas von Woedtke, INP, Greifswald: Cold plasma in anti-tuberculosis therapy